OBJECTIVE: To report the incidence of @entity5 by geography, race or ethnicity, and histology. METHODS: We examined combined data from the National Program of @entity5 Registries and the Surveillance, Epidemiology, and End Results Program covering 87% of the U.S. population. We calculated the age-adjusted incidence of @entity5 by age, race or ethnicity, histology, and stage by region or state. RESULTS: Rates of invasive @entity5 per 100,000 females declined from 10.2 in 1998 to 8.5 in 2002. Incidence rates by state ranged from 6.6 to 12.3 per 100,000. Rates were especially high among Hispanic @entity1 aged 40 years or older (26.5 or more) and African-American @entity1 aged older than 50 years (23.5 or more). Rates of @entity957 were significantly higher among African-American and Hispanic @entity1 than among their white counterparts. In contrast, rates of @entity420 (18% of all cases) were significantly lower among African-American @entity1 than in white @entity1 (rate ratio 0.88, P<.05). Rates of @entity420 were significantly higher among Hispanic @entity1 than among non-Hispanics (rate ratio 1.71, P<.05). Although no regional differences were noted for @entity420 , rates of @entity957 were higher in the South than in other regions. CONCLUSION: Despite intense screening in the past decade, higher rates of @entity5 persist among @entity1 in the South and @entity1 who are African American or Hispanic. This information could guide more focused interventions to increase access to screening with cervical cytology as well as vaccination against @entity1082 . LEVEL OF EVIDENCE: III.

XXXX incidence in a prevaccine era in the United States, 1998-2002.

@entity1 :: ('9606', 'Species') :: ['women'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'cervical cancer', 'Cancer'] @entity957 :: ('MESH:D002294', 'Disease') :: ['squamous cell carcinoma'] @entity1082 :: ('10566', 'Species') :: ['human papillomavirus'] @entity420 :: ('MESH:D000230', 'Disease') :: ['adenocarcinoma']
@entity5 :: (MESH:D009369,Disease) :: ['Cervical cancer']
